ATG5 and syringocystadenoma papilliferum: Since chemicals have (i) potential side effects independent of autophagy and (ii) do not completely and continuously block autophagy, we also developed a genetic approach and established SCAP cell lines in which Atg5 or Atg7 genes were deleted by a CRISPR/CAS9 strategy.